Insights derived from analysing SEC filings. Independent analysis, not a publication of the SEC.
Figures are read from the filings of Kulicke and Soffa Industries, Inc. (central index key 56978): the Form 10-K for FY2026 filed 19 Nov 2026 and the Forms 10-K for FY2023 to FY2025, the Forms 10-Q for Q1 to Q3 FY2026, the Forms 8-K with all their exhibits, incl. the quarterly results releases (Ex 99.1) for Q1 FY2025 to Q4 FY2026, the CEO offer letter and appointment release, the amended incentive plan and the Item 5.07 vote results, the proxy statement of 22 Jan 2026, Schedules 13G and Forms 4, together with the Forms 10-Q and 10-K of Teradyne and Onto Innovation and the Applied Materials figures used in this series' Applied Materials post. Kulicke & Soffa files no separate CFO commentary document; CFO commentary is the statement of Lester Wong, Interim CEO and CFO from Dec 2025 to Aug 2026, in each results release. No earnings call content is used. Accession numbers appear in the Sources appendix. Share prices are closes of 18 Nov 2026, the day the Q4 FY2026 release was filed.
| Segment | Q4 FY2025 | Q4 FY2026 | Change (%) | FY2025 | FY2026 | Change (%) | Share FY2026 (%) |
|---|---|---|---|---|---|---|---|
| Ball Bonding Equipment | 91.0 | 271.4 | 198.3 | 293.0 | 768.0 | 162.2 | 64.9 |
| Wedge Bonding Equipment | 20.0 | 42.3 | 110.9 | 110.6 | 102.3 | (7.5) | 8.6 |
| Advanced Solutions | 16.1 | 41.6 | 158.4 | 72.7 | 112.7 | 55.0 | 9.5 |
| APS | 33.8 | 40.9 | 21.2 | 128.9 | 151.0 | 17.2 | 12.8 |
| All Others | 16.7 | 14.0 | (15.9) | 48.9 | 48.9 | 0.0 | 4.1 |
| Total | 177.6 | 410.3 | 131.1 | 654.1 | 1,182.9 | 80.9 | 100.0 |
| Segment | Gross margin FY2025 (%) | Gross margin FY2026 (%) | Operating income FY2025 ($m) | Operating income FY2026 ($m) | Operating margin FY2025 (%) | Operating margin FY2026 (%) |
|---|---|---|---|---|---|---|
| Ball Bonding Equipment | 50.0 | 49.9 | 84.4 | 303.6 | 28.8 | 39.5 |
| Wedge Bonding Equipment | 45.1 | 40.6 | 18.4 | 3.9 | 16.6 | 3.8 |
| Advanced Solutions | 58.0 | 44.4 | 49.4 | (38.4) | 67.9 | (34.0) |
| APS | 51.6 | 50.9 | 44.4 | 50.2 | 34.5 | 33.3 |
| All Others | (54.7) | 42.6 | (104.8) | (1.3) | (214.3) | (2.6) |
| Unallocated corporate expenses | n/a | n/a | (95.0) | (106.3) | n/a | n/a |
| Total | 42.5 | 48.4 | (3.2) | 211.8 | (0.5) | 17.9 |
| End market | FY2024 | FY2025 | FY2026 | Change FY2026 (%) | Share FY2026 (%) |
|---|---|---|---|---|---|
| General Semiconductor | 333.8 | 334.2 | 804.1 | 140.6 | 68.0 |
| Memory | 73.6 | 53.4 | 104.7 | 95.9 | 8.8 |
| Automotive and Industrial | 138.8 | 110.4 | 95.3 | (13.7) | 8.1 |
| APS | 160.0 | 156.1 | 178.9 | 14.6 | 15.1 |
| Country | FY2024 | FY2025 | FY2026 | Change FY2026 (%) | Share FY2026 (%) |
|---|---|---|---|---|---|
| China | 416.7 | 363.6 | 795.4 | 118.8 | 67.2 |
| Taiwan | 59.3 | 55.0 | 87.9 | 59.7 | 7.4 |
| United States | 66.1 | 62.2 | 70.9 | 14.0 | 6.0 |
| Malaysia | 54.3 | 45.8 | 58.8 | 28.4 | 5.0 |
| All others | 109.8 | 127.4 | 169.9 | 33.3 | 14.4 |
| Company and measure | Period | Detail | Value | Change year on year (%) |
|---|---|---|---|---|
| Kulicke & Soffa, Ball Bonding revenue ($m) | Oct 2026 quarter | operating margin 41.6%; FY2026 $768.0m | 271.4 | 198.3 |
| Kulicke & Soffa, total revenue ($m) | Oct 2026 quarter | operating margin 21.2% | 410.3 | 131.1 |
| Teradyne, Semiconductor Test revenue ($m) | Sep 2026 quarter | pretax segment income $366.9m; memory test $301m | 1,072.0 | 76.9 |
| Onto Innovation, revenue ($m) | Sep 2026 quarter | gross margin 54.8%; incl. Semilab USA | 409.7 | 87.8 |
| Applied Materials, Semiconductor Systems revenue ($m) | Oct 2026 quarter | DRAM 33% of segment revenue | 7,996.0 | 63.9 |
| Company and measure | Period | Detail | Value | Change year on year (%) |
|---|---|---|---|---|
| Kulicke & Soffa, Advanced Solutions revenue ($m) | Oct 2026 quarter | FY2026 $112.7m, +55.0%; operating loss | 41.6 | 158.4 |
| Onto Innovation, systems and software revenue ($m) | Sep 2026 quarter | total revenue $409.7m, +87.8% | 358.3 | 106.2 |
| Applied Materials, total revenue ($m) | Oct 2026 quarter | stake in Besi to rise to about 20% | 10,409.0 | 53.1 |
| Teradyne, Product Test revenue ($m) | Sep 2026 quarter | pretax segment income $41.4m | 138.1 | 56.5 |
| Company and measure | Period | Detail | Value | Change year on year (%) |
|---|---|---|---|---|
| Kulicke & Soffa, APS revenue ($m) | Oct 2026 quarter | FY2026 $151.0m, operating margin 33.3% | 40.9 | 21.2 |
| Applied Materials, Applied Global Services revenue ($m) | Oct 2026 quarter | services, spares and automation software | 1,896.0 | 25.9 |
| Onto Innovation, parts and services revenue ($m) | Sep 2026 quarter | parts $28.5m, services $23.0m | 51.4 | 15.8 |
| Line item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | 1,503.6 | 742.5 | 706.2 | 654.1 | 1,182.9 |
| Gross profit | 748.3 | 358.7 | 268.8 | 277.9 | 572.6 |
| Research and development | 136.9 | 144.7 | 151.2 | 149.6 | 172.5 |
| Selling, general and administrative | 140.1 | 153.0 | 165.6 | 167.7 | 187.3 |
| Operating income | 470.1 | 39.4 | (92.5) | (3.2) | 211.8 |
| Net income | 433.5 | 57.1 | (69.0) | 0.2 | 182.6 |
| Diluted EPS ($) | 7.09 | 0.99 | (1.24) | 0.00 | 3.42 |
| Operating cash flow | 390.2 | 173.4 | 31.0 | 112.4 | 71.9 |
| Capital expenditure | (23.0) | (44.4) | (16.1) | (17.2) | (21.8) |
| Free cash flow | 367.2 | 129.0 | 14.9 | 95.2 | 50.1 |
| Stock based compensation | 19.0 | 22.7 | 26.9 | 28.5 | 26.9 |
| Cash and investments | 775.5 | 759.4 | 577.1 | 510.7 | 517.0 |
| Total debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Total equity | 1,194.7 | 1,174.6 | 944.0 | 821.5 | 982.0 |
| Metric | Q4 FY2025 | Q4 FY2026 | Change |
|---|---|---|---|
| Revenue ($m) | 177.6 | 410.3 | 131.1% |
| Gross profit ($m) | 81.2 | 196.0 | 141.3% |
| Operating income ($m) | 0.9 | 87.2 | n/a |
| Net income ($m) | 6.4 | 73.2 | 1,048.0% |
| Diluted EPS ($) | 0.12 | 1.37 | 1,041.7% |
| Operating cash flow ($m) | 7.4 | 25.4 | 242.4% |
| Free cash flow ($m) | 4.4 | 14.6 | 227.5% |
| Operating margin (%) | 0.5 | 21.2 | 20.7 pts |
| Net margin (%) | 3.6 | 17.8 | 14.3 pts |
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Growth and margins | |||||
| Revenue growth (%) | n/a | (50.6) | (4.9) | (7.4) | 80.9 |
| Gross margin (%) | 49.8 | 48.3 | 38.1 | 42.5 | 48.4 |
| Operating margin (%) | 31.3 | 5.3 | (13.1) | (0.5) | 17.9 |
| Net margin (%) | 28.8 | 7.7 | (9.8) | 0.0 | 15.4 |
| FCF margin (%) | 24.4 | 17.4 | 2.1 | 14.6 | 4.2 |
| Cost and investment intensity | |||||
| R&D (%) revenue | 9.1 | 19.5 | 21.4 | 22.9 | 14.6 |
| SBC (%) revenue | 1.3 | 3.1 | 3.8 | 4.4 | 2.3 |
| Capex (%) revenue | 1.5 | 6.0 | 2.3 | 2.6 | 1.8 |
| Effective tax rate (%) | 9.1 | 20.8 | n/a | 99.0 | 21.1 |
| Returns | |||||
| ROE (%) | 36.3 | 4.8 | (6.5) | 0.0 | 20.2 |
| ROA (%) | 27.3 | 3.7 | (5.0) | 0.0 | 14.3 |
| ROIC (%) | 101.9 | 7.5 | (20.7) | (0.9) | 35.9 |
| Asset turnover (x) | 0.95 | 0.50 | 0.57 | 0.59 | 0.82 |
| Liquidity and leverage | |||||
| Current ratio (x) | 5.36 | 6.55 | 5.41 | 4.79 | 3.37 |
| Debt to equity (x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net cash ($bn) | 0.8 | 0.8 | 0.6 | 0.5 | 0.5 |
| Efficiency and cash quality | |||||
| Days sales outstanding | 75 | 78 | 100 | 102 | 131 |
| Inventory days | 89 | 207 | 148 | 155 | 142 |
| FCF to net income (x) | 0.85 | 2.26 | n/a | 446.98 | 0.27 |
| Shareholder returns (%) FCF | 87 | 86 | 1,309 | 159 | 85 |
| Measure | Value |
|---|---|
| Market value ($bn) | 3.5 |
| Enterprise value, net cash of $517.0m deducted ($bn) | 3.0 |
| P/E on FY2026 diluted EPS of $3.42 (x) | 19.6 |
| P/E on FY2026 non GAAP EPS of $3.95 (x) | 17.0 |
| P/E on Q1 FY2027 non GAAP EPS outlook of $1.65 annualized (x) | 10.2 |
| EV/Sales, FY2026 (x) | 2.6 |
| Free cash flow yield, FY2026 (%) | 1.4 |
| Dividend yield at $0.205 a quarter (%) | 1.2 |
| Price to book (x) | 3.6 |
| Line | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Cost of sales (% of revenue) | 50.2 | 51.7 | 61.9 | 57.5 | 51.6 |
| Research and development (% of revenue) | 9.1 | 19.5 | 21.4 | 22.9 | 14.6 |
| Selling, general and administrative (% of revenue) | 9.3 | 20.6 | 23.4 | 25.6 | 15.8 |
| Capital expenditure (% of revenue) | 1.5 | 6.0 | 2.3 | 2.6 | 1.8 |
| Operating income (% of revenue) | 31.3 | 5.3 | (13.1) | (0.5) | 17.9 |
| Line | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | Q3 FY2026 | Q4 FY2026 |
|---|---|---|---|---|---|
| Revenue ($m) | 177.6 | 199.6 | 242.6 | 330.4 | 410.3 |
| Gross margin, US GAAP (%) | 45.7 | 49.6 | 49.3 | 47.8 | 47.8 |
| Operating margin, US GAAP (%) | 0.5 | 8.9 | 15.9 | 20.7 | 21.2 |
| Operating margin, non GAAP (%) | 6.6 | 12.6 | 19.1 | 22.9 | 23.5 |
| Research and development ($m) | 38.8 | 40.4 | 38.4 | 43.9 | 49.8 |
| Selling, general and administrative ($m) | 41.5 | 40.8 | 42.7 | 45.8 | 58.0 |
| Diluted EPS, US GAAP ($) | 0.12 | 0.32 | 0.66 | 1.07 | 1.37 |
| Diluted EPS, non GAAP ($) | 0.28 | 0.44 | 0.79 | 1.20 | 1.52 |
| Item ($m unless stated) | Q4 FY2026 | Q4 FY2025 | FY2026 | FY2025 |
|---|---|---|---|---|
| GAAP net income ($m) | 73.2 | 6.4 | 182.6 | 0.2 |
| Equity based compensation | 7.5 | 7.8 | 26.9 | 28.5 |
| Restructuring | 0.6 | 2.8 | 3.2 | 12.7 |
| Impairment charges | 0.9 | n/a | 0.9 | 39.8 |
| Amortization of acquired intangibles | 0.3 | 0.3 | 1.2 | 3.0 |
| Gain relating to cessation of business | n/a | n/a | n/a | (76.0) |
| Other items and tax effect of adjustments | (1.2) | (2.4) | (3.9) | 2.7 |
| Non GAAP net income ($m) | 81.4 | 14.9 | 210.9 | 11.0 |
| Non GAAP diluted EPS ($) | 1.52 | 0.28 | 3.95 | 0.21 |
| Line | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | Q3 FY2026 | Q4 FY2026 |
|---|---|---|---|---|---|
| Operating cash flow | 7.4 | (8.9) | 10.3 | 45.2 | 25.4 |
| Capital expenditure | (3.0) | (2.7) | (4.1) | (4.3) | (10.8) |
| Free cash flow | 4.4 | (11.6) | 6.2 | 40.9 | 14.6 |
| Share repurchases | (16.7) | (6.7) | (0.1) | (0.5) | (3.1) |
| Item | Outlook | Source |
|---|---|---|
| Q2 FY2025 outlook (4 Feb 2025) | revenue $165m +/‑ $10m; non GAAP EPS $0.19 +/‑ 10%; actual $162.0m and ($0.52) | 8-K Ex 99.1 of 4 Feb 2025 and 6 May 2025 |
| Q3 FY2025 outlook (6 May 2025) | revenue $145m +/‑ $10m; non GAAP EPS $0.05 +/‑ 10%; actual $148.4m and $0.07 | 8-K Ex 99.1 of 6 May 2025 and 6 Aug 2025 |
| Q4 FY2025 outlook (6 Aug 2025) | revenue $170m +/‑ $10m; non GAAP EPS $0.22 +/‑ 10%; actual $177.6m and $0.28 | 8-K Ex 99.1 of 6 Aug 2025 and 19 Nov 2025 |
| Q1 FY2026 outlook (19 Nov 2025) | revenue $190m +/‑ $10m; GAAP EPS $0.18, non GAAP EPS $0.33, each +/‑ 10%; actual $199.6m, $0.32 and $0.44 | 8-K Ex 99.1 of 19 Nov 2025 and 4 Feb 2026 |
| Q2 FY2026 outlook (4 Feb 2026) | revenue $230m +/‑ $10m; GAAP EPS $0.53, non GAAP EPS $0.67; actual $242.6m, $0.66 and $0.79 | 8-K Ex 99.1 of 4 Feb 2026 and 6 May 2026 |
| Q3 FY2026 outlook (6 May 2026) | revenue $310m +/‑ $20m; GAAP EPS $0.87, non GAAP EPS $1.00; actual $330.4m, $1.07 and $1.20 | 8-K Ex 99.1 of 6 May 2026 and 5 Aug 2026 |
| Q4 FY2026 outlook (5 Aug 2026) | revenue $375m +/‑ $20m; GAAP EPS $1.29, non GAAP EPS $1.42; actual $410.3m, $1.37 and $1.52 | 8-K Ex 99.1 of 5 Aug 2026 and 18 Nov 2026 |
| Q1 FY2027 outlook (18 Nov 2026), quarter to 2 Jan 2027 | revenue $410m +/‑ $20m; GAAP EPS $1.48, non GAAP EPS $1.65, each +/‑ 10%; GAAP operating expenses $98.9m +/‑ 2%; 53.5m diluted shares | 8-K Ex 99.1 of 18 Nov 2026 |
| FY2026 capital expenditure | raised to about $22m from about $12m (May 2026) to expand TCB production for up to about $400m of annual TCB system sales; actual $21.8m | 8-K Ex 99.1 of 6 May 2026; FY2026 Form 10-K |
| FY2027 capital expenditure | $30.0m to $34.0m | FY2026 Form 10-K, Item 7 |
| Advanced Solutions production | expanded facility to be completed in H2 FY2027 (Aug 2026); system manufacturing began on the new Singapore production floor in Q1 FY2027 (Nov 2026) | 8-K Ex 99.1 of 5 Aug 2026 and 18 Nov 2026 |
| Speaker | Date and source | Statement |
|---|---|---|
| Lester Wong, Interim CEO and CFO | 6 May 2026, 8-K Ex 99.1 | “Demand is stronger than anticipated due to both technology and capacity needs” |
| Lester Wong, Interim CEO and CFO | 5 Aug 2026, 8-K Ex 99.1 | “demand conditions continue to improve across all end markets” |
| Raj Talluri, President and CEO | 18 Nov 2026, 8-K Ex 99.1 | “core wire bonding demand is resilient” |
| Item | Disclosure |
|---|---|
| FY2026 Form 10-K, Item 1 | Customers are IDMs, OSATs, foundries and electronics makers; 94.0% of FY2026 revenue shipped outside the US and 56.3% went to customers headquartered in China (53.5% in FY2025). |
| FY2026 Form 10-K, Item 1, backlog | Backlog $720.3m at 3 Oct 2026 against $245.3m; FY2026 bookings $1.66bn against $750.8m; most orders can be cancelled or deferred with limited or no penalties. |
| FY2026 Form 10-K, Item 1, competition | Named equipment competitors: ASM Pacific Technology, Hesse, Han's Laser, BE Semiconductor Industries, Hanwha Precision Machinery, Hanmi Semiconductor and Nordson. |
| FY2026 Form 10-K, Item 1, products | APTURA fluxless thermo compression bonding targets high performance computing, high bandwidth memory and co packaged optics; ATPremier MEM PLUS vertical wire for DRAM and NAND (Mar 2025); ASTERION TW terminal welding for power modules. |
| FY2026 Form 10-K, Item 1, people | 2,500 full time employees and 476 temporary workers at 3 Oct 2026; CEO Fusen Chen retired 1 Dec 2025; Raj Talluri CEO from 1 Sep 2026. |
| FY2026 Form 10-K, Note 16 | Haoseng Industrial was 16.1% and Tianshui Huatian Technology 13.5% of FY2026 revenue; the two held 32.6% and 22.2% of receivables at 3 Oct 2026. |
| FY2026 Form 10-K, Note 15 | Destination sales to China $795.4m (67.2% of revenue) against $363.6m; long lived assets $103.5m, of which Singapore $58.4m. |
| FY2026 Form 10-K, Item 7 | Inventory purchase obligations $608.7m at 3 Oct 2026, of which $607.2m due within a year (Apr 2026: $359.6m); no borrowings other than a bank guarantee. |
| FY2026 Form 10-K, Item 7, liquidity | Cash and short term investments $517.0m, of which $334.8m held by foreign subsidiaries; receivables rose $241.8m and inventories $87.5m in FY2026. |
| FY2026 Form 10-K, Item 5 | $223.3m left under the $300m buyback program at 3 Oct 2026; Q4 FY2026 purchases of 35 thousand shares at $84.04 to $96.15; dividend $0.205 a quarter. |
| FY2026 Form 10-K, Note 17 | Wind down of the Electronics Assembly equipment business substantially completed, subject to last time orders; FY2025 included a $71.1m Project reimbursement and $39.8m of impairments. |
| FY2026 Form 10-K, Note 16, warranty | Warranty provision $19.6m in FY2026 against $9.4m; reserve $13.1m at year end against $7.3m. |
| Q3 FY2026 Form 10-Q, MD&A | Ball Bonding revenue +$150.1m year on year in Q3: general semiconductor $126.6m, memory $19.4m, automotive and industrial $4.1m; Advanced Solutions gross margin 34.7% against 46.8% on product mix. |
| Q2 FY2026 Form 10-Q, MD&A | Wedge Bonding revenue (63.9%) in Q2 on lower EV capacity needs; Ball Bonding gross margin 48.3% against 50.8% on customer mix. |
| FY2026 Forms 10-Q, Part II Item 1A | Each of the three FY2026 quarterly reports states no material change to the FY2025 risk factors. |
| Company | Revenue TTM ($bn) | Revenue growth (%) | Gross margin (%) | Operating margin (%) | Net margin (%) | FCF margin (%) | ROE (%) | Net cash ($bn) | Market value ($bn) | EV/Sales (x) | P/E TTM (x) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| KLIC | 1.2 | 131.1 | 48.4 | 17.9 | 15.4 | 4.2 | 20.2 | 0.5 | 4 | 2.6 | 19.6 |
| AMAT | 34.5 | 53.1 | 50.0 | 32.2 | 29.3 | 18.0 | 43.4 | 7.6 | 302 | 8.6 | 30.2 |
| TER | 5.0 | 69.8 | 59.3 | 32.1 | 27.5 | 20.5 | 42.4 | 0.6 | 37 | 7.2 | 27.0 |
| ONTO | 1.3 | 87.8 | 51.7 | 15.7 | 11.5 | 18.9 | 7.4 | (0.2) | 10 | 7.7 | 66.1 |
| Date | Items | Event |
|---|---|---|
| 19 Nov 2025 | 2.02, 9.01 | Q4 FY2025 results: revenue $177.6m, GAAP EPS $0.12, non GAAP EPS $0.28; FY2025 revenue $654.1m, net income $0.2m; Q1 FY2026 outlook $190m |
| 4 Feb 2026 | 2.02, 9.01 | Q1 FY2026 results: revenue $199.6m +20.2%, GAAP EPS $0.32, non GAAP EPS $0.44; Q2 outlook $230m |
| 5 Mar 2026 | 5.07 | Annual meeting of 4 Mar 2026: Peter T. Kong and Jon A. Olson elected; PwC ratified; say on pay approved |
| 6 May 2026 | 2.02, 9.01 | Q2 FY2026 results: revenue $242.6m +49.8%, GAAP EPS $0.66, non GAAP EPS $0.79; FY2026 capex raised to about $22m for TCB capacity of up to about $400m a year; Q3 outlook $310m |
| 5 Aug 2026 | 2.02, 9.01 | Q3 FY2026 results: revenue $330.4m +122.6%, GAAP EPS $1.07, non GAAP EPS $1.20; Q4 outlook $375m |
| 17 Aug 2026 | 5.02, 7.01, 9.01 | Dr. Raj Talluri appointed President and CEO from 1 Sep 2026 and director from 17 Aug 2026; $750,000 salary, 110% target bonus, $14.0m new hire equity award; Lester Wong remains CFO |
| 14 Oct 2026 | 5.02, 9.01 | Amended Incentive Compensation Plan for FY2027: operating profit and gross margin (50% each) replace net income and operating margin; 15% individual goals for the Executive Leadership Team |
| 18 Nov 2026 | 2.02, 9.01 | Q4 FY2026 results: revenue $410.3m +131.1%, GAAP EPS $1.37, non GAAP EPS $1.52; FY2026 revenue $1.18bn, EPS $3.42; Q1 FY2027 outlook $410m |
| Contract | Terms |
|---|---|
| CEO offer letter, Raj Talluri (13 Aug 2026) | Salary $750,000; target bonus 110% of salary; new hire equity award of $14.0m (half RSUs over three years, half PSUs on relative total shareholder return); annual award $6.0m (40% RSUs, 60% PSUs); 24 months of salary on termination without cause; salary and target bonus times two on a change in control. |
| Incentive Compensation Plan (amended 13 Oct 2026) | From FY2027 corporate measures are operating profit and gross margin, 50% each, in place of net income and operating margin; Executive Leadership Team awards 85% corporate and 15% individual goals. |
| Share repurchase program | $300m program announced 13 Nov 2024 with a Rule 10b5‑1 plan from 2 Dec 2024 to 2 Dec 2029; $223.3m remaining at 3 Oct 2026. |
| Inventory purchase obligations | $608.7m at 3 Oct 2026, of which $607.2m due in FY2027; part non cancellable and part subject to cancellation charges (Form 10-K Item 7). |
| Cancelled Project (FY2025) | $71.1m reimbursement of costs from a customer on cancellation of a development and mass production project, recorded in FY2025 within the gain on cessation of business (Form 10-K). |
| Proposal | For (m votes) | Against (m votes) | Abstain (m votes) | For as % of votes cast | Result |
|---|---|---|---|---|---|
| Election of director: Peter T. Kong | 39.8 | 3.9 | n/a | 91.0 | Elected (against = withheld) |
| Election of director: Jon A. Olson | 42.7 | 1.1 | n/a | 97.6 | Elected (against = withheld) |
| Ratify PricewaterhouseCoopers for FY2026 | 46.1 | 0.3 | 0.1 | 99.3 | Approved |
| Say on pay (non binding) | 41.1 | 2.5 | 0.1 | 94.2 | Approved |
| Insider | Role | Sales | Detail |
|---|---|---|---|
| Lester Wong | Interim CEO and CFO, then CFO | $7.30m | 60,000 shares at $121.71 (18 Jun 2026) |
| Nelson Wong | Senior Vice President | $6.09m | 90,004 shares Dec 2025 to Jun 2026 at $50.07 to $113.72; 70,000 under Rule 10b5‑1 plans |
| Mui Sung Yeo | Director | $3.38m | 19,143 shares at $71.98 (13 Feb 2026); 20,000 at $100.00 (20 May 2026) |
| David Richardson | Director | $0.68m | 9,364 shares at $72.20 (25 Feb 2026) |
| Robert Chylak | Senior Vice President | $0.52m | 7,098 shares at $73.28 (10 Feb 2026) |
| Zi Yao Lim | General Counsel | $0.27m | 3,500 shares in three sales, Dec 2025 to May 2026 |
| Peter Kong | Chair | $0.17m | 1,551 shares at $110.00 (11 Jun 2026) |
| Risk | Disclosure and change |
|---|---|
| China exposure and export controls | China destination sales 67.2% of FY2026 revenue; customers headquartered in China 56.3%; the export factor now names BIS controls on advanced computing and high bandwidth memory. |
| Customer concentration | Haoseng Industrial 16.1% and Tianshui Huatian 13.5% of FY2026 revenue; 32.6% and 22.2% of receivables at 3 Oct 2026 (54.8% together). |
| Order cancellation and backlog | Backlog $720.3m, most of it cancellable or deferrable with limited or no penalties; purchase obligations $608.7m. |
| Cyclical demand | Revenue fell from $1.50bn in FY2022 to $654.1m in FY2025 before rising to $1.18bn in FY2026; the 10-K states that visibility is limited. |
| Advanced Solutions returns | Segment operating loss of ($38.4m) in FY2026 on $112.7m of revenue; segment capital expenditure $17.1m of $27.1m for all segments (Note 15); cash paid for property, plant and equipment $21.8m. |
| Supply and logistics | Supply of certain chips, components and materials was constrained at times in FY2026; Super Typhoon Bavi disrupted freight in Jun and Jul 2026. |
| Measure | 10-K FY2025 | 10-K FY2026 |
|---|---|---|
| Risk factors (count) | 33 | 34 |
| Words in Item 1A | 10,973 | 9,558 |
| Change | Risk factor | What changed |
|---|---|---|
| Added | Processing of personal data | New factor on US state privacy laws and the EU General Data Protection Regulation and the cost of complying with differing rules. |
| Added | Use of AI and emerging technologies | New factor: AI in business processes brings risks of inaccurate output, data leakage and loss of confidential information under AI rules that differ by US state and country. |
| Removed | Other changes in taxation | Merged into the tax factor, now titled changes in effective tax rate or tax legislation. |
| Reworded | Political instability, tensions and war | Text on the Israel and Gaza conflict and the Haifa capillary plant removed; the factor is 187 words shorter. |
| Reworded | Dependence on suppliers | States that in FY2026 supply of certain chips, components and specialized materials was constrained at times; earlier text on easing constraints removed. |
| Reworded | Quarterly results fluctuate | Bullet list replaced by one paragraph naming order cancellations, component costs, restructuring and inventory write offs; 97 words shorter. |
| Reworded | Operations outside the US | List of plants by country removed; the factor is 308 words shorter. |
| Reworded | Catastrophic events and climate | Taiwan earthquake example of Jan 2025 replaced by Super Typhoon Bavi, which disrupted freight between Jun and Jul 2026. |
| Reworded | Export restrictions and trade wars | Rewritten around the Export Administration Regulations and BIS controls on semiconductors, advanced computing and high bandwidth memory; 419 words shorter. |
| Reworded | Customer concentration | Adds Haoseng Industrial at 16.1% of FY2026 revenue. |
| Reworded | Cessation of the EA business | Wind down now substantially completed, subject to last time orders. |
| Reworded | Key employees | Refers to the retirement in FY2026 of the former CEO and of the head of K&S Products and Solutions. |
| Reworded | IT disruptions and cyber attacks | Rewritten to name insider threats, third party failures and attacks that use AI; 459 words shorter. |
| Reworded | New ERP system | Shortened by 140 words; names data integrity issues, delays and cost overruns. |
| Reworded | Effective tax rate and tax law | Adds valuation allowances, transfer pricing and the Jan 2026 OECD side by side safe harbor for US parented groups; OBBBA text removed. |
| Filing | Change disclosed |
|---|---|
| 10-Q Q1 FY2026 filed 5 Feb 2026 | No material change from the FY2025 risk factors. |
| 10-Q Q2 FY2026 filed 7 May 2026 | No material change from the FY2025 risk factors. |
| 10-Q Q3 FY2026 filed 6 Aug 2026 | No material change from the FY2025 risk factors. |
| Factor | Current value | Best case requires | Evidence in filings |
|---|---|---|---|
| Ball Bonding demand | Q4 FY2026 $271.4m, +198.3%; FY2026 $768.0m, +162.2% | segment revenue holds near the FY2026 Q4 rate through FY2027 instead of falling back toward FY2023 to FY2025 levels | FY2026 Form 10-K; 8-K Ex 99.1 of 18 Nov 2026 |
| TCB and Advanced Solutions | FY2026 $112.7m, operating loss ($38.4m) | TCB system sales toward the up to about $400m a year that the expanded production is to support, with a segment profit | 8-K Ex 99.1 of 6 May and 18 Nov 2026 |
| Orders and backlog | backlog $720.3m; FY2026 bookings $1.66bn | bookings above revenue in FY2027 | FY2026 Form 10-K Item 7 |
| Operating margin | Q4 FY2026 21.2%; FY2026 17.9% | 26% in FY2029; FY2022 margin was 31.3% | Forms 10-K |
| China customers | China 67.2% of FY2026 destination sales | no new export rules that cut China revenue | FY2026 Form 10-K Item 1A and Note 15 |
| Capital return | $10.4m of buybacks in FY2026 as stated in the release ($10.5m paid in the cash flow statement); $223.3m authorization left; $0.82 a share dividend | share count down about 2% by FY2029 | FY2026 Form 10-K Item 5 |
| Measure | Worst case | Base case | Best case |
|---|---|---|---|
| Revenue CAGR, 3 years (%) | (12.0) | 8.0 | 20.0 |
| Revenue, FY2029 ($bn) | 0.8 | 1.5 | 2.0 |
| Operating margin, FY2029 (%) | 8.0 | 20.0 | 26.0 |
| Net income, FY2029 ($bn) | 0.1 | 0.2 | 0.4 |
| EPS, FY2029 ($) | 1.19 | 4.72 | 8.33 |
| Exit P/E (x) | 16.0 | 17.0 | 22.0 |
| Implied price ($) | 19 | 80 | 183 |
| Change against $66.99 (%) | (72) | 20 | 174 |
| Implied annual return (%) | (34.3) | 6.2 | 39.9 |
| Revenue CAGR \ Operating margin | 8% | 14% | 20% | 23% | 26% |
|---|---|---|---|---|---|
| (12%) | $20 | $33 | $45 | $51 | $58 |
| 0% | $28 | $46 | $65 | $74 | $83 |
| 8% | $34 | $57 | $80 | $92 | $103 |
| 14% | $40 | $67 | $94 | $107 | $121 |
| 20% | $46 | $77 | $109 | $124 | $140 |
| Exit P/E \ Operating margin | 8% | 14% | 20% | 23% | 26% |
|---|---|---|---|---|---|
| 12x | $24 | $40 | $57 | $65 | $73 |
| 14x | $28 | $47 | $66 | $76 | $85 |
| 17x | $34 | $57 | $80 | $92 | $103 |
| 20x | $41 | $67 | $94 | $108 | $121 |
| 22x | $45 | $74 | $104 | $119 | $134 |
This analysis is for information only and is not financial advice. It is derived from public SEC filings retrieved via sec-api.io and is not a publication of the U.S. Securities and Exchange Commission. Scenario values are model outputs under stated assumptions and are not forecasts. Data as of 19 November 2026.
All company figures are read from SEC filings retrieved through the sec-api.io MCP server, under central index key 56978 (Kulicke and Soffa Industries, Inc.). Peer figures come from the Forms 10-Q and 10-K of Teradyne and Onto Innovation and the Forms 8-K of Applied Materials. Share prices are closes of 18 Nov 2026 (Applied Materials 12 Nov 2026) and monthly closes.
| Form | Period | Filed | Accession number |
|---|---|---|---|
| 10-K | FY2026 | 19 Nov 2026 | 0000056978-26-000040 |
| 8-K Ex 99.1 | Q4 FY2026 | 18 Nov 2026 | 0000056978-26-000038 |
| 8-K Ex 10.1 | 13 Oct 2026 | 14 Oct 2026 | 0000056978-26-000036 |
| 8-K Ex 10.1, 99.1 | 13 Aug 2026 | 17 Aug 2026 | 0000056978-26-000034 |
| 10-Q | Q3 FY2026 | 6 Aug 2026 | 0000056978-26-000032 |
| 8-K Ex 99.1 | Q3 FY2026 | 5 Aug 2026 | 0000056978-26-000030 |
| 10-Q | Q2 FY2026 | 7 May 2026 | 0000056978-26-000020 |
| 8-K Ex 99.1 | Q2 FY2026 | 6 May 2026 | 0000056978-26-000018 |
| 8-K Item 5.07 | 4 Mar 2026 | 5 Mar 2026 | 0000056978-26-000014 |
| 10-Q | Q1 FY2026 | 5 Feb 2026 | 0000056978-26-000012 |
| 8-K Ex 99.1 | Q1 FY2026 | 4 Feb 2026 | 0000056978-26-000010 |
| DEF 14A | 2026 annual meeting | 22 Jan 2026 | 0000056978-26-000006 |
| 10-K | FY2025 | 20 Nov 2025 | 0000056978-25-000081 |
| 8-K Ex 99.1 | Q4 FY2025 | 19 Nov 2025 | 0000056978-25-000078 |
| 8-K Ex 99.1 | Q3 FY2025 | 6 Aug 2025 | 0000056978-25-000070 |
| 8-K Ex 99.1 | Q2 FY2025 | 6 May 2025 | 0000056978-25-000054 |
| 8-K Ex 99.1 | Q1 FY2025 | 4 Feb 2025 | 0000056978-25-000027 |
| 10-K | FY2024 | 14 Nov 2024 | 0000056978-24-000148 |
| 10-K | FY2023 | 16 Nov 2023 | 0000056978-23-000172 |
| Schedule 13G/A | 30 Sep 2026 | 13 Oct 2026 | 0000019617-26-000359 |
| Schedule 13G | 30 Jun 2026 | 31 Jul 2026 | 0002100121-26-000957 |
| Schedule 13G | 30 Jun 2026 | 16 Jul 2026 | 0000019617-26-000267 |
| Schedule 13G/A | 13 Mar 2026 | 26 Mar 2026 | 0000102909-26-000424 |
| Schedule 13G/A | 30 Sep 2025 | 31 Oct 2025 | 0001040188-25-000088 |
| Schedule 13G/A | 31 Mar 2025 | 30 Apr 2025 | 0002052113-25-001959 |
| Company | Form | Filed | Accession number |
|---|---|---|---|
| Kulicke & Soffa | 4 (59 transactions, example) | 22 Jun 2026 | 0001529306-26-000003 |
| Applied Materials | 8-K Ex 99.1 | 13 Aug 2026 | 0001628280-26-056699 |
| Applied Materials | 8-K | 26 Oct 2026 | 0001628280-26-067303 |
| Applied Materials | 8-K Ex 99.1 | 12 Nov 2026 | 0001628280-26-073360 |
| Onto Innovation | 10-K | 24 Feb 2026 | 0001193125-26-066937 |
| Onto Innovation | 10-Q | 9 Nov 2026 | 0001193125-26-453859 |
| Teradyne | 10-K | 19 Feb 2026 | 0001193125-26-059002 |
| Teradyne | 10-Q | 30 Oct 2026 | 0001193125-26-441091 |
| Filed | Exhibit | Document | Content |
|---|---|---|---|
| 19 Nov 2025 | Ex 99.1 | Q4 and FY2025 results release | Q4 FY2025 revenue $177.6m; GAAP EPS $0.12; non GAAP EPS $0.28; FY2025 revenue $654.1m; net income $0.2m; gross margin 42.5% |
| 4 Feb 2026 | Ex 99.1 | Q1 FY2026 results release | Revenue $199.6m; gross margin 49.6%; GAAP EPS $0.32; non GAAP EPS $0.44; Operating cash flow ($8.9m); buybacks $6.7m |
| 6 May 2026 | Ex 99.1 | Q2 FY2026 results release | Revenue $242.6m; gross margin 49.3%; GAAP EPS $0.66; non GAAP EPS $0.79; FY2026 capex to about $22m from about $12m for TCB capacity of up to about $400m a year |
| 5 Aug 2026 | Ex 99.1 | Q3 FY2026 results release | Revenue $330.4m; gross margin 47.8%; GAAP EPS $1.07; non GAAP EPS $1.20; Expanded Advanced Solutions facility to be completed in H2 FY2027 |
| 17 Aug 2026 | Ex 10.1 | Offer letter, Dr. Raj Talluri | Salary $750,000; target bonus 110% of salary; New hire equity award $14.0m (50% RSUs, 50% PSUs on relative TSR); annual award $6.0m |
| 17 Aug 2026 | Ex 99.1 | CEO appointment release | Raj Talluri CEO from 1 Sep 2026; previously CEO of Enovix and SVP at Micron; Lester Wong remains EVP and CFO |
| 14 Oct 2026 | Ex 10.1 | Amended Incentive Compensation Plan (FY2027) | Operating profit and gross margin, 50% each, replace net income and operating margin; Executive Leadership Team awards 85% corporate, 15% individual goals |
| 18 Nov 2026 | Ex 99.1 | Q4 and FY2026 results release | Q4 revenue $410.3m; GAAP EPS $1.37; non GAAP EPS $1.52; FY2026 revenue $1.18bn; GAAP EPS $3.42; non GAAP EPS $3.95; adjusted free cash flow $50.2m |
November 19, 2026·39 min read
November 19, 2026·37 min read